Novartis AG (NVS) income statement
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$150.47−0.75 (-0.50%)
Close on Nov 20, 2026Market cap $287.12BP/E 21.0Yield –
Novartis AG financial ratios
See a number that looks wrong?